ANLN在肝内胆管癌中的表达及对胆管癌细胞增殖的影响
|
摘要
目的:探讨ANLN基因在肝内胆管癌组织中的表达情况以及在胆管癌细胞增殖中的作用及机制。方法:收集手术切除的40例肝内胆管癌患者癌组织及癌旁组织,采用RT-PCR、Western blot以及免疫组化的方法检测组织中ANLN mRNA和蛋白表达水平,比较ANLN在肝内胆管癌组织与癌旁组织中的表达差异,分析其与肿瘤分期及肿瘤大小的关系。使用小干扰RNA建立ANLN低表达HUCCT1细胞系,行CCK8、平板克隆以及流式细胞检测观察ANLN对胆管癌细胞体外增殖能力的影响。行String软件预测与ANLN相关的蛋白,行RT-PCR、Western blot方法检测两者间的相关性以及周期蛋白CyclinD1表达差异。结果:Western blot和RT-PCR显示ANLN在肝内胆管癌组织中高表达。临床数据分析显示ANLN的表达与肝内胆管癌患者的肿瘤大小及TNM分期密切相关,并且ANLN表达高的患者预后较差。利用小干扰RNA(siRNA)下调ANLN能有效抑制胆管癌细胞的增殖能力。Western blot实验证明下调ANLN导致周期蛋白Cyclin D1、Cyclin A表达明显减少。String预测ANLN与TPX2相关,经Western blot和RT-PCR得到验证。结论:ANLN可能通过TPX2调节肝内胆管癌细胞的增殖能力,促进肝内胆管癌的发展,这可为肝内胆管癌的治疗提供新靶点。
Objective:To investigate the expression of ANLN in intrahepatic cholangiocarcinoma(ICC)and explored the function of ANLN in proliferation of ICC in vivo. Methods:We used the Western blot and real-time PCR(RT-PCR)to quantify the expression of ANLN in cancerous tissues and adjacent tissues of 40 patients with ICC. The differences in the expression of ANLN in ICC and the adjacent tissues of cancer were compared,and its relationship with tumor staging and tumor size was analyzed. ANLN low expression HUCCT1 cell lines were established using small interference RNA(siRNA). The cell proliferation was investigated by cell counting kit-8 assay(CCK-8),colony formation and cell cycle arrest. In addition,the proteins that regulate ANLN expression in CCA were selected by using String,and the relationship between them was verified by Western blot and RT-PCR. Results:The results of Western blot and RT-PCR revealed that ANLN was highly expressed in ICC tissues. Clinical data analysis showed that the expression of ANLN was closely related to the tumor size and TNM stage in patients with cholangiocarcinoma,and the prognosis of patients with high ANLN expression was poor. The reduction of ANLN by siRNA could effectively inhibit the proliferation ability of cholangiocarcinoma cells.Western blot showed that the reduction of ANLN led to a significant decrease in the expressions of periodic protein cyclin D1 and cyclin A. String showed that TPX2 may play a major role in the regulation of ANLN expression,Western blot and RT-PCR further validated the positive relationship between ANLN and TPX2. Conclusion:ANLN regulates the proliferation of cholangiocarcinoma cells,which promotes the development of ICC and provides a new target for the treatment of ICC.
Objective:To investigate the expression of ANLN in intrahepatic cholangiocarcinoma(ICC)and explored the function of ANLN in proliferation of ICC in vivo. Methods:We used the Western blot and real-time PCR(RT-PCR)to quantify the expression of ANLN in cancerous tissues and adjacent tissues of 40 patients with ICC. The differences in the expression of ANLN in ICC and the adjacent tissues of cancer were compared,and its relationship with tumor staging and tumor size was analyzed. ANLN low expression HUCCT1 cell lines were established using small interference RNA(siRNA). The cell proliferation was investigated by cell counting kit-8 assay(CCK-8),colony formation and cell cycle arrest. In addition,the proteins that regulate ANLN expression in CCA were selected by using String,and the relationship between them was verified by Western blot and RT-PCR. Results:The results of Western blot and RT-PCR revealed that ANLN was highly expressed in ICC tissues. Clinical data analysis showed that the expression of ANLN was closely related to the tumor size and TNM stage in patients with cholangiocarcinoma,and the prognosis of patients with high ANLN expression was poor. The reduction of ANLN by siRNA could effectively inhibit the proliferation ability of cholangiocarcinoma cells.Western blot showed that the reduction of ANLN led to a significant decrease in the expressions of periodic protein cyclin D1 and cyclin A. String showed that TPX2 may play a major role in the regulation of ANLN expression,Western blot and RT-PCR further validated the positive relationship between ANLN and TPX2. Conclusion:ANLN regulates the proliferation of cholangiocarcinoma cells,which promotes the development of ICC and provides a new target for the treatment of ICC.
引文
[1] Khan SA,Taylor-Robinson SD,Toledano MB,et al. Changing international trends in mortality rates for liver,biliary and pancreatic tumours[J]. J Hepatol,2002,37(6):806-813
[2] Khan SA,Toledano MB,Taylor-Robinson SD. Epidemiology,risk factors,and pathogenesis of cholangiocarcinoma[J]. HPB(Oxford),2008,10(2):77-82
[3] Esnaola NF,Meyer JE,Karachristos A,et al. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma[J]. Cancer,2016,122(9):1349-1369
[4] Mavros MN,Economopoulos KP,Alexiou VG,et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma:systematic review and meta-analysis[J].JAMA Surg,2014,149(6):565-574
[5] Nathan H,Pawlik TM,Wolfgang CL,et al. Trends in survival after surgery for cholangiocarcinoma:a 30-year population-based SEER database analysis[J]. J Gastrointest Surg,2007,11(11):1488-1496
[6] Khan SA,Thomas HC,Davidson BR,et al. Cholangiocarcinoma[J]. Lancet,2005,366(9493):1303-1314
[7] Piekny AJ,Maddox AS. The myriad roles of anillin during cytokinesis[J]. Semin Cell Dev Biol,2010,21(9):881-891
[8] Oegema K,Savoian MS,Mitchison TJ,et al. Functional analysis of a human homologue of the Drosophila actin binding protein anillin suggests a role in cytokinesis[J]. J Cell Biol,2000,150(3):539-552
[9] den Hollander P,Savage MI,Brown PH. Targeted therapy for breast cancer prevention[J]. Front Oncol,2013,3:250
[10] Labrie F. Drug insight:breast cancer prevention and tissue-targeted hormone replacement therapy[J]. Nat Clin Pract Endocrinol Metab,2007,3(8):584-593
[11] Suzuki C,Daigo Y,Ishikawa N,et al. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide3-kinase/AKT pathway[J]. Cancer Res,2005,65(24):11314-11325
[12]Yamasaki S. Intrahepatic cholangiocarcinoma:macroscopic type and stage classification[J]. J Hepatobiliary Pancreat Surg,2003,10(4):288-291
[13]Wu JQ,Kuhn JR,Kovar DR,et al. Spatial and temporal pathway for assembly and constriction of the contractile ring in fission yeast cytokinesis[J]. Dev Cell,2003,5(5):723-734
[14]Olakowski M,Tyszkiewicz T,Jarzab M,et al. NBL1 and anillin(ANLN)genes over-expression in pancreatic carcinoma[J]. Folia Histochem Cytobiol,2009,47(2):249-255
[15]Hall PA,Todd CB,Hyland PL,et al. The septin-binding protein anillin is overexpressed in diverse human tumors[J]. Clin Cancer Res,2005,11(19 Pt 1):6780-6786
[16] Wieczorek M,Bechstedt S,Chaaban S,et al. Microtubuleassociated proteins control the kinetics of microtubule nucleation[J]. Nat Cell Biol,2015,17(7):907-916
[17] Giubettini M,Asteriti IA,Scrofani J,et al. Control of Aurora-A stability through interaction with TPX2[J]. J Cell Sci,2011,124(Pt 1):113-122
[18]Miwa T,Kokuryo T,Yokoyama Y,et al. Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer[J]. Cancer Med,2015,4(7):1091-1100
[19] Wei P,Zhang N,Xu Y,et al. TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer[J].J Transl Med,2013,11:313
[2] Khan SA,Toledano MB,Taylor-Robinson SD. Epidemiology,risk factors,and pathogenesis of cholangiocarcinoma[J]. HPB(Oxford),2008,10(2):77-82
[3] Esnaola NF,Meyer JE,Karachristos A,et al. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma[J]. Cancer,2016,122(9):1349-1369
[4] Mavros MN,Economopoulos KP,Alexiou VG,et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma:systematic review and meta-analysis[J].JAMA Surg,2014,149(6):565-574
[5] Nathan H,Pawlik TM,Wolfgang CL,et al. Trends in survival after surgery for cholangiocarcinoma:a 30-year population-based SEER database analysis[J]. J Gastrointest Surg,2007,11(11):1488-1496
[6] Khan SA,Thomas HC,Davidson BR,et al. Cholangiocarcinoma[J]. Lancet,2005,366(9493):1303-1314
[7] Piekny AJ,Maddox AS. The myriad roles of anillin during cytokinesis[J]. Semin Cell Dev Biol,2010,21(9):881-891
[8] Oegema K,Savoian MS,Mitchison TJ,et al. Functional analysis of a human homologue of the Drosophila actin binding protein anillin suggests a role in cytokinesis[J]. J Cell Biol,2000,150(3):539-552
[9] den Hollander P,Savage MI,Brown PH. Targeted therapy for breast cancer prevention[J]. Front Oncol,2013,3:250
[10] Labrie F. Drug insight:breast cancer prevention and tissue-targeted hormone replacement therapy[J]. Nat Clin Pract Endocrinol Metab,2007,3(8):584-593
[11] Suzuki C,Daigo Y,Ishikawa N,et al. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide3-kinase/AKT pathway[J]. Cancer Res,2005,65(24):11314-11325
[12]Yamasaki S. Intrahepatic cholangiocarcinoma:macroscopic type and stage classification[J]. J Hepatobiliary Pancreat Surg,2003,10(4):288-291
[13]Wu JQ,Kuhn JR,Kovar DR,et al. Spatial and temporal pathway for assembly and constriction of the contractile ring in fission yeast cytokinesis[J]. Dev Cell,2003,5(5):723-734
[14]Olakowski M,Tyszkiewicz T,Jarzab M,et al. NBL1 and anillin(ANLN)genes over-expression in pancreatic carcinoma[J]. Folia Histochem Cytobiol,2009,47(2):249-255
[15]Hall PA,Todd CB,Hyland PL,et al. The septin-binding protein anillin is overexpressed in diverse human tumors[J]. Clin Cancer Res,2005,11(19 Pt 1):6780-6786
[16] Wieczorek M,Bechstedt S,Chaaban S,et al. Microtubuleassociated proteins control the kinetics of microtubule nucleation[J]. Nat Cell Biol,2015,17(7):907-916
[17] Giubettini M,Asteriti IA,Scrofani J,et al. Control of Aurora-A stability through interaction with TPX2[J]. J Cell Sci,2011,124(Pt 1):113-122
[18]Miwa T,Kokuryo T,Yokoyama Y,et al. Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer[J]. Cancer Med,2015,4(7):1091-1100
[19] Wei P,Zhang N,Xu Y,et al. TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer[J].J Transl Med,2013,11:313
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |